Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agilon Health (AGL) Liabilities and Shareholders Equity (2020 - 2025)

Historic Liabilities and Shareholders Equity for Agilon Health (AGL) over the last 6 years, with Q3 2025 value amounting to $1.6 billion.

  • Agilon Health's Liabilities and Shareholders Equity fell 2367.62% to $1.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $7.0 billion, marking a year-over-year decrease of 1607.39%. This contributed to the annual value of $1.7 billion for FY2024, which is 39.54% down from last year.
  • Per Agilon Health's latest filing, its Liabilities and Shareholders Equity stood at $1.6 billion for Q3 2025, which was down 2367.62% from $1.7 billion recorded in Q2 2025.
  • Over the past 5 years, Agilon Health's Liabilities and Shareholders Equity peaked at $2.4 billion during Q2 2023, and registered a low of $574.0 million during Q1 2021.
  • Its 5-year average for Liabilities and Shareholders Equity is $1.8 billion, with a median of $1.8 billion in 2022.
  • In the last 5 years, Agilon Health's Liabilities and Shareholders Equity surged by 25537.42% in 2021 and then tumbled by 2367.62% in 2025.
  • Quarter analysis of 5 years shows Agilon Health's Liabilities and Shareholders Equity stood at $1.6 billion in 2021, then rose by 7.01% to $1.7 billion in 2022, then rose by 2.56% to $1.7 billion in 2023, then fell by 0.4% to $1.7 billion in 2024, then dropped by 7.94% to $1.6 billion in 2025.
  • Its last three reported values are $1.6 billion in Q3 2025, $1.7 billion for Q2 2025, and $1.9 billion during Q1 2025.